Get the Stockscreener App
11.49
0.70%
0.08
After Hours:
11.49
Cadrenal Therapeutics Inc stock is traded at $11.49, with a volume of 9,117.
It is up +0.70% in the last 24 hours and up +11.01% over the past month.
Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy. Tecarfarin is a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation.
See More
Previous Close:
$11.41
Open:
$11.58
24h Volume:
9,117
Relative Volume:
0.34
Market Cap:
$22.60M
Revenue:
-
Net Income/Loss:
$-4.85M
P/E Ratio:
-37.06
EPS:
-0.31
Net Cash Flow:
$-3.95M
1W Performance:
+1.77%
1M Performance:
+11.01%
6M Performance:
-40.59%
1Y Performance:
+77.40%
1-Day Range:
$11.25
$11.58
1-Week Range:
$10.45
$11.98
52-Week Range:
$5.70
$22.90
Cadrenal Therapeutics Inc Stock (CVKD) Company Profile
Name
Cadrenal Therapeutics Inc
Sector
Industry
Phone
904-300-0701
Address
822 A1A NORTH, PONTE VEDRA
Compare CVKD with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CVKD
Cadrenal Therapeutics Inc
|
11.49 | 22.44M | 0 | -4.85M | -3.95M | -0.31 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.65 | 121.28B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.10 | 60.96B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.81 | 42.77B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
591.99 | 36.21B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
291.47 | 32.08B | 3.81B | -644.79M | -669.77M | -6.24 |
Cadrenal Therapeutics Inc Stock (CVKD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-18-23 | Initiated | Noble Capital Markets | Outperform |
Cadrenal Therapeutics Inc Stock (CVKD) Latest News
How strong is Cadrenal Therapeutics Inc. company’s balance sheetHigh-yield investments - jammulinksnews.com
Should I hold or sell Cadrenal Therapeutics Inc. stock in 2025Realize consistent double-digit growth - jammulinksnews.com
Why CARGO Therapeutics Inc. stock attracts strong analyst attentionFree Long-Term Wealth Growth Plan - Newser
Why ONEW stock attracts strong analyst attentionDaily Stock Radar - Newser
Published on: 2025-07-27 19:16:14 - jammulinksnews.com
Key External Factors That Drive Playtika Holding Corp. Stock Price MovementsWeekly Big Movers - Newser
How Cadrenal Therapeutics Inc. stock performs during market volatilityDouble Your Capital Alerts - Newser
Pineapple Company Inc.: Is It Leading or LaggingReal Time Alert Service - Newser
What is the risk reward ratio of investing in Cadrenal Therapeutics Inc. stockGet alerts on the hottest stocks daily - jammulinksnews.com
How volatile is Cadrenal Therapeutics Inc. stock compared to the marketGet professional advice for market timing - jammulinksnews.com
Why Cadrenal Therapeutics Inc. stock attracts strong analyst attentionInsider Level Guidance - Newser
Why EFOI stock attracts strong analyst attentionSmart Money Signals - Metal.it
What drives Cadrenal Therapeutics Inc. stock priceJaw-dropping returns - PrintWeekIndia
P 500Consistent high-performance stocks - jammulinksnews.com
Cadrenal Therapeutics Inc. Stock Analysis and ForecastExceptional market performance - Autocar Professional
Is Cadrenal Therapeutics Inc. a good long term investmentHigh-yield market plays - jammulinksnews.com
Outlook Therapeutics Inc. Stock Analysis and ForecastExplosive market performance - jammulinksnews.com
What analysts say about Cadrenal Therapeutics Inc. stockConsistently outstanding ROI - jammulinksnews.com
Monetizing Your Website through AdSenseSolid Return Trade Selections - Newser
(CVKD) Technical Pivots with Risk Controls - news.stocktradersdaily.com
What analysts say about TLSA stockOutstanding risk-reward balance - PrintWeekIndia
Cadrenal Therapeutics Director Resignation Announced - The Globe and Mail
Future of HOHOHO V2.0(santa floki v2) ExplainedEarly Breakout Tracker - Newser
Cadrenal Therapeutics director resigns; annual meeting set for September - Investing.com Australia
Candel Therapeutics (CADL) Shares Soar 9.60% - AInvest
What makes Cadrenal Therapeutics Inc. stock price move sharplyFree Capital Allocation Plans - Newser
Cadrenal Therapeutics Inc Stock (CVKD) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.97%
0.22%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):